Science in Blood Donation Act of 2020
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Science in Blood Donation Act of 2020
This bill requires the Food and Drug Administration (FDA) to revise its guidance on reducing the risk of transmitting by blood transfusion human immunodeficiency virus, hepatitis A, and hepatitis B.
Specifically, the FDA shall update its guidance to remove recommendations to not receive blood donations from a man who had sex with another man in the past three months. The FDA shall also remove recommendations to not receive blood donations from a woman who in the last three months had sex with such a man.
The FDA's updated guidance shall be based on an individual risk assessment of sexual behaviors that evaluate all donors equally without regard to sexual orientation or gender identity.
Referred to the House Committee on Energy and Commerce.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8168: Science in Blood Donation Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-8168/
"H.R. 8168: Science in Blood Donation Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-8168/.
H.R. 8168, 116th Cong. (2026), https://openamerica.io/bill/116-HR-8168/.
[H.R. 8168: Science in Blood Donation Act of 2020](https://openamerica.io/bill/116-HR-8168/)